Eliquis image

Anti-blood clotting drug Eliquis gets NICE nod

March 6, 2015
Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting

Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …

scott_byrd

Acacia Pharma appoints two directors to board

March 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acacia pharma, christine soden, scott byrd

UK pharma firm Acacia Pharma that develops drugs for supportive care has confirmed Scott Byrd and Christine Soden have joined …

GSK image

GlaxoSmithKline in major opium deal

March 5, 2015
Sales and Marketing GSK, GlaxoSmithKline, Sun Pharma, opium, tasmania

GSK is to sell its opiates business to Sun Pharmaceuticals for an undisclosed amount, the two companies have announced. The …

NHS image

Government lays out rare diseases plan

March 5, 2015
Sales and Marketing Department of Health, NHS, UK, government, howe, rare diseases

The UK government has set out new plans to improve the lives of patients with rare diseases by 2020. The …

BMS image

BMS’ Opdivo wins US lung cancer race

March 5, 2015
Research and Development, Sales and Marketing BMS, Prostvac, biosciences, flexus, lung cancer, oncology, opdivo

The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer …

Abbbie image

AbbVie buys Pharmacyclics in $21 billion deal

March 5, 2015
Sales and Marketing AbbVie, Humira, Johnson and Johnson, Pharmacyclics, adalimumab, imbruvica

AbbVie has secured Californian biotech Pharmacyclics and beat Johnson & Johnson to gain control of blockbuster blood cancer therapy Imbruvica in …

rafael_amado

Adaptimmune makes executive hires from GSK

March 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Adrian Rawcliffe, Rafael Amado

UK and US clinical-stage biotech firm Adaptimmune has increased its senior team with the appointment of Dr Rafael Amado as …

Eisai image

Eisai Alzheimer’s drug to see China review

March 4, 2015
Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride

Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …

Teva image

Teva to sell US manufacturing plant

March 4, 2015
Manufacturing and Production, Sales and Marketing G&W Laboratories, Pennsylvania, Teva

Teva Pharmaceutical has announced that it has signed an agreement to sell a US manufacturing facility to G&W Laboratories. The …

EU widens indications for Pfizer vaccine

March 4, 2015
Research and Development, Sales and Marketing EC, EMA, Pfizer, pneumococcal polysaccharide conjugate vaccine, prevenar

Pfizer has gained approval from the European Commission which has signed off on an EMA decision to recommend Prevenar 13 …

Christophe Weber image

New chief executive for Takeda

March 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actos, Millennium, Nycomed, Takeda, Yasuchika Hasegawa, christophe weber

Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …

Scottish reforms proven to work says SMC

March 4, 2015
Sales and Marketing NHS, NICE, Onglyza, PACE, SMC, Scotland, anne lee, scottish

The chief pharma advisor for the Scottish Medicines Consortium Anne Lee says changes to its processes have contributed to improved …

richard_douglas

Finance director general for Department of Health retiring

March 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, DoH, director general, finance, richard douglas

The Department of Health’s director general for finance and the NHS Richard Douglas is to retire at the end of …

AZ image

AstraZeneca completes respiratory deal with Actavis

March 3, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast

AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …

Boehringer image

Boehringer chases approval for anti-Pradaxa drug

March 3, 2015
Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa, bleeding, dabigatran etexilate, idarucizumab

Boehringer Ingelheim is launching new drug applications for its investigational treatment to reverse the effects of its blood-thinning drug Pradaxa. …

Takeda image

Takeda expands in Singapore

March 3, 2015
Manufacturing and Production Singapore, Takeda, biopolis, emerging markets, vaccines

Japanese pharma giant Takeda has set up new Singapore offices in the Biopolis biomedical complex with the aim of expanding …

Chiesi image

Chiesi reprimanded again over Fostair drug

March 3, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA, code, formoterol/beclometason, fostair

Chiesi has been reprimanded after it breached the ABPI’s Code of Practice for its promotion of asthma inhaler Fostair. The …

Harvoni image

NICE recommends Harvoni for hepatitis C

March 3, 2015
Sales and Marketing Gilead, NICE, harvoni, hepatitis C, ledipasvir-sofosbuvir

NICE has signalled a provisional OK for Gilead’s Harvoni to be used as a treatment for hepatitis C by the …

beth_ratliff

Premise Health senior joins Nashville Health Care Council

March 3, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing nashville health care council, premise health

US worksite health and patient engagement firm Premise Health has announced that its senior VP Beth Ratliff has been selected …

Ebola image

ZMapp trials start in Liberia

March 2, 2015
Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp

Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …

The Gateway to Local Adoption Series

Latest content